Nitazoxanide cas: 55981-09-4

CAS NO: 55981-09-4
Nitazoxanide
Description Review
Description

Nitazoxanide (CAS: 55981-09-4) is a broad-spectrum antiprotozoal and antiviral agent that is used to treat a variety of infectious diseases. It was first approved by the US Food and Drug Administration (FDA) in 2002 and has since become a widely prescribed medication.

Chemical Name: The chemical name of Nitazoxanide is 2-acetyloxy-N-(5-nitro-2-thiazolyl) benzamide.

Molecular Formula: The molecular formula of Nitazoxanide is C12H9N3O5S.

Formula Weight: The formula weight of Nitazoxanide is 307.28 g/mol.

CAS No: The CAS number of Nitazoxanide is 55981-09-4.

Top Ten Keywords from Google and Synonyms:

  1. Anti-protozoal medication
  2. Antiviral medication
  3. Broad-spectrum medication
  4. Diarrhea treatment
  5. Nitazoxanide
  6. Nitazoxanide uses
  7. Nitazoxanide dosage
  8. Nitazoxanide side effects
  9. Alinia
  10. Daxon

Health benefits of this product: Nitazoxanide is primarily used to treat infectious diseases caused by protozoa and viruses. It has been shown to be effective against a wide range of pathogens, including Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica, rotavirus, and norovirus. Nitazoxanide is particularly effective in treating diarrhea caused by these pathogens. It has also been used to treat other infections, including hepatitis B and C, influenza, and coronavirus (SARS-CoV-2).

Potential effects: Nitazoxanide has been shown to have several potential effects on the body. It has been demonstrated to have broad-spectrum antiparasitic and antiviral activity, meaning it can target a wide range of infectious agents. Additionally, Nitazoxanide has been found to have immunomodulatory effects, which means it can help regulate the body's immune response. This could be particularly useful in treating viral infections, where an overactive immune response can cause damage to the body.

Product mechanism: Nitazoxanide works by inhibiting various metabolic pathways in the targeted pathogens. It interferes with the ability of the pathogen to produce energy and replicate, eventually leading to its death. Additionally, Nitazoxanide has been shown to have immunomodulatory effects, meaning it can help regulate the body's immune response. This could be particularly beneficial in treating viral infections.

Safety: Nitazoxanide is generally considered to be safe and well-tolerated. Most side effects are mild and include nausea, diarrhea, and abdominal pain. Rarely, more serious side effects such as allergic reactions may occur. Nitazoxanide should not be used in people with severe liver or kidney disease. It is also not recommended for pregnant women or children under one year of age.

Side effects: The most common side effects of Nitazoxanide include nausea, diarrhea, and abdominal pain. These are typically mild and go away on their own after a few days. More serious side effects, such as allergic reactions or liver damage, are rare.

Dosing information: The recommended dose of Nitazoxanide varies depending on the condition being treated. For the treatment of diarrhea caused by Giardia or Cryptosporidium, the recommended dose is 500 mg twice daily for three days. For the treatment of influenza or other viral infections,

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code